180 related articles for article (PubMed ID: 17203172)
21. Correlative expression of cyclooxygenase-1 (Cox-1) and human epidermal growth factor receptor type-2 (Her-2) in endometrial cancer.
Sugimoto T; Koizumi T; Sudo T; Yamaguchi S; Kojima A; Kumagai S; Nishimura R
Kobe J Med Sci; 2007; 53(5):177-87. PubMed ID: 18204294
[TBL] [Abstract][Full Text] [Related]
22. A role of thymidine phosphorylase and P53 tissue protein expression in biology of endometrial cancer.
Mazurek A; Kuć P; Mazurek-Wadołkowska E; Laudański T
Neoplasma; 2008; 55(3):261-5. PubMed ID: 18348659
[TBL] [Abstract][Full Text] [Related]
23. Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma.
Massi D; Naldini A; Ardinghi C; Carraro F; Franchi A; Paglierani M; Tarantini F; Ketabchi S; Cirino G; Hollenberg MD; Geppetti P; Santucci M
Hum Pathol; 2005 Jun; 36(6):676-85. PubMed ID: 16021575
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional regulation of beta1 integrin expression in the physio/pathological states of human endometrial tissues.
Moro L; Greco M; Maiorano E; Selvaggi L; Marra E; Perlino E
Int J Oncol; 2005 Feb; 26(2):457-65. PubMed ID: 15645131
[TBL] [Abstract][Full Text] [Related]
25. Role of protease activated receptor-2 in tumor advancement of ovarian cancers.
Jahan I; Fujimoto J; Alam SM; Sato E; Sakaguchi H; Tamaya T
Ann Oncol; 2007 Sep; 18(9):1506-12. PubMed ID: 17761706
[TBL] [Abstract][Full Text] [Related]
26. A large-scale gene expression comparison of microdissected, small-sized endometrial cancers with or without hyperplasia matched to same-patient normal tissue.
Sugiyama Y; Dan S; Yoshida Y; Akiyama F; Sugiyama K; Hirai Y; Matsuura M; Miyata S; Ushijima M; Hasumi K; Yamori T
Clin Cancer Res; 2003 Nov; 9(15):5589-600. PubMed ID: 14654540
[TBL] [Abstract][Full Text] [Related]
27. [Intermediate-conductance-Ca2+-activated K+ channels are overexpressed in endometrial cancer and involved in regulating proliferation of endometrial cancer cells].
Wang ZH; Feng YJ; Su M; Yi XF
Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):111-5. PubMed ID: 17442186
[TBL] [Abstract][Full Text] [Related]
28. [Expression of estrogen receptor-related receptor isoforms in endometrial carcinoma tissues and its clinical significance].
Gao M; Wei LH; Sun PM; Zhao D; Wang JL; Wang ZQ; Zhao C
Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):756-60. PubMed ID: 16324250
[TBL] [Abstract][Full Text] [Related]
29. [Angiogenesis related gene expression profiles of human endometrial endothelial cells isolated from tissue of endometrial cancer].
Du XL; Sheng XG; Yan CX; Liu T; Wang C; Song QQ; Li QS
Zhonghua Fu Chan Ke Za Zhi; 2012 Oct; 47(10):756-63. PubMed ID: 23302734
[TBL] [Abstract][Full Text] [Related]
30. [Expression and significance of gonadotropin-releasing hormone receptor in the endometrium of normal and endometrial cancer uterus].
Yue Y; Piao JX; Wang LN; Pu JW; Gao FD
Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):326-8. PubMed ID: 16762189
[TBL] [Abstract][Full Text] [Related]
31. Correlation between VEGFR-2 receptor kinase domain-containing receptor (KDR) mRNA and angiotensin II receptor type 1 (AT1-R) mRNA in endometrial cancer.
Piastowska-Ciesielska AW; Płuciennik E; Wójcik-Krowiranda K; Bieńkiewicz A; Nowakowska M; Pospiech K; Bednarek AK; Domińska K; Ochędalski T
Cytokine; 2013 Feb; 61(2):639-44. PubMed ID: 23273598
[TBL] [Abstract][Full Text] [Related]
32. Expression of the epidermal growth factor system in endometrioid endometrial cancer.
Ejskjaer K; Sørensen BS; Poulsen SS; Forman A; Nexø E; Mogensen O
Gynecol Oncol; 2007 Jan; 104(1):158-67. PubMed ID: 16962163
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of CD44 variants 6 and 7 in human endometrial cancer.
Katsura M; Furumoto H; Nishimura M; Kamada M; Aono T
Gynecol Oncol; 1998 Nov; 71(2):185-9. PubMed ID: 9826458
[TBL] [Abstract][Full Text] [Related]
34. Macrophage infiltration and angiogenesis in endometrial cancer.
Hashimoto I; Kodama J; Seki N; Hongo A; Miyagi Y; Yoshinouchi M; Kudo T
Anticancer Res; 2000; 20(6C):4853-6. PubMed ID: 11205231
[TBL] [Abstract][Full Text] [Related]
35. Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers.
Bakkum-Gamez JN; Aletti G; Lewis KA; Keeney GL; Thomas BM; Navarro-Teulon I; Cliby WA
Gynecol Oncol; 2008 Jan; 108(1):141-8. PubMed ID: 17988723
[TBL] [Abstract][Full Text] [Related]
36. Expression of protease activated receptor-2 (PAR-2) in gastric cancer.
Fujimoto D; Hirono Y; Goi T; Katayama K; Hirose K; Yamaguchi A
J Surg Oncol; 2006 Feb; 93(2):139-44. PubMed ID: 16425301
[TBL] [Abstract][Full Text] [Related]
37. Protease-activated receptor-2 (PAR-2) in cervical cancer proliferation.
Sánchez-Hernández PE; Ramirez-Dueñas MG; Albarran-Somoza B; García-Iglesias T; del Toro-Arreola A; Franco-Topete R; Daneri-Navarro A
Gynecol Oncol; 2008 Jan; 108(1):19-26. PubMed ID: 17936340
[TBL] [Abstract][Full Text] [Related]
38. Urocortin expression is downregulated in human endometrial carcinoma.
Florio P; De Falco G; Leucci E; Torricelli M; Torres PB; Toti P; Dell'Anna A; Tiso E; Santopietro R; Leoncini L; Petraglia F
J Endocrinol; 2006 Jul; 190(1):99-105. PubMed ID: 16837614
[TBL] [Abstract][Full Text] [Related]
39. Expression of protease-activated receptor-2 (PAR-2) in patients with nasopharyngeal carcinoma: correlation with clinicopathological features and prognosis.
Li Z; Bian LJ; Li Y; Liang YJ; Liang HZ
Pathol Res Pract; 2009; 205(8):542-50. PubMed ID: 19269113
[TBL] [Abstract][Full Text] [Related]
40. Protease-activated receptor-2 expression and the role of trypsin in cell proliferation in human pancreatic cancers.
Ohta T; Shimizu K; Yi S; Takamura H; Amaya K; Kitagawa H; Kayahara M; Ninomiya I; Fushida S; Fujimura T; Nishimura G; Miwa K
Int J Oncol; 2003 Jul; 23(1):61-6. PubMed ID: 12792776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
